GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

LTR Pharma LTP.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.46

+8.33%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$183,928

FY2021FY2026

Net income

−A$14.2m

FY2021FY2026

Free cash flow

—

FY2021FY2026

Shareholders' equity

A$20.3m

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
RevenueA$183,928A$2.1mA$49,330A$90A$9,320—
Research and developmentA$6.7mA$2.8mA$3.5mA$817,835A$348,305—
Operating income−A$14.5m−A$5.2m−A$6.4m−A$1.4m−A$1.0m−A$28,570
Net income−A$14.2m−A$5.6m−A$7.0m−A$1.5m−A$1.0m−A$40,803
Diluted earnings per share-0.08-0.03-0.04-0.01-0.01-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assetsA$20.9mA$32.2mA$3.4mA$2.1mA$2.2mA$422,700
Cash and short-term investments—A$31.8mA$3.1mA$1.7mA$1.9m—
Total liabilitiesA$601,490A$700,570A$428,540A$21,260A$475,910A$463,503
Shareholders' equityA$20.3mA$31.5mA$2.9mA$2.1mA$1.8m−A$40,803
Shares outstanding182m182m181m139m182m182m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations——−A$5.1m−A$1.5m−A$568,180—
Capital spending−A$5,946−A$13,168−A$1,980−A$1,990——
Free cash flow——−A$5.1m−A$1.5m−A$568,180—

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023
RevenueA$587,060A$1.7mA$451,260A$49,240A$90
Operating income−A$5.4m−A$3.0m−A$2.2m−A$4.0m−A$2.4m
Net income−A$5.8m−A$3.2m−A$2.4m−A$4.4m−A$2.5m
Diluted earnings per share-0.03-0.02-0.01-0.02-0.02
Cash from operations——−A$2.0m−A$5.0m—
Total assetsA$27.3mA$32.2mA$34.7mA$3.4mA$6.6m
Cash and short-term investmentsA$25.8mA$31.8mA$34.1mA$3.1mA$6.0m
Shareholders' equityA$26.9mA$31.5mA$34.3mA$2.9mA$6.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1169.0%——
Operating income117.7%247.8%—
Net income113.5%222.2%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-861.8%-1178.0%——
Net margin-863.7%-1205.3%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023
Price to earnings-5.5-23.4-21.1-33.1
Price to sales425.062.2——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.